Skip to main content
Market intelligence
MIRMHealthcare

Mirum Pharmaceuticals Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 14, 2026Eric BjerkholtCHIEF FINANCIAL OFFICERSale9,943$98.37$978,093
Sep 2, 2026Jolanda HoweSVP, GLOBAL CONTROLLERSale658$100.00$65,800
Sep 1, 2026Christopher PeetzCHIEF EXECUTIVE OFFICERSale30,000$98.68$2,960,400